Bartlett & Co’s Abiomed Inc ABMD Stock Holding History

Bartlett & Co’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-59	Closed	-$14K	–	1197
2022 Q3	$14K	Hold	59	–	–	﹤0.01%	771
2022 Q2	$15K	Hold	59	–	–	﹤0.01%	792
2022 Q1	$20K	Buy	+59	New	+$18.2K	﹤0.01%	732
2020 Q4	–	Sell	-40	Closed	-$11K	–	1208
2020 Q3	$11K	Buy	+40	New	+$11.5K	﹤0.01%	678

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bartlett & Co's ABMD Position: Q4 2022 in Review

Bartlett & Co sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 59 shares — an estimated $14K sold.

Bartlett & Co first reported a position in ABMD in Q3 2020 and held it in 4 quarters. The position peaked at $20K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Bartlett & Co reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Bartlett & Co sold 59 Abiomed Inc shares in Q4 2022, an estimated $14K.
Bartlett & Co first reported a position in Abiomed Inc in Q3 2020 and held it in 4 quarters.
Bartlett & Co's Abiomed Inc position peaked at $20K in Q1 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Bartlett & Co's 13F filing for Q4 2022, filed 4 Jan 2023.